InVivo Therapeutics Announces Appointment of Ann Merrifield as Lead Director

InVivo Therapeutics Holdings Corp. (NVIV) today announced the Company’s Board of Directors has appointed independent director Ann Merrifield to the newly created position of Lead Director. The Lead Director will serve as a liaison between the Chairman and non-management directors, chair all executive sessions, and work with the Chairman on meeting agendas and time schedules for the Board of Directors, according to a Business Wire press release.

“Ann Merrifield’s deep industry knowledge and expertise has proven to be invaluable since joining the Board of Directors in November 2014,” said Mark Perrin, InVivo’s Chief Executive Officer and Chairman. “Her proven leadership capabilities make her an excellent choice for Lead Director, and I look forward to working closely with her."

The Company’s Board of Directors also approved splitting the Governance, Nominating, and Compensation Committee into two committees: the Nominating and Corporate Governance Committee and the Compensation Committee. Ann Merrifield has been appointed as the new Chairwoman of the Nominating and Corporate Governance Committee. Kenneth DiPietro will serve as Chairman of the newly created Compensation Committee, and John McCarthy, Jr. will continue to serve as the Audit Committee Chairman.

Click here for the full press release.